Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |